Obagi Medical Products Announces Collaboration With Nextcell Medical

Obagi Medical Products, wholly owned subsidiary of Valeant Pharmaceuticals International (NYSE:VRX,TSX:VRX), announced a collaboration with Nextcell Medical Company for the exclusive distribution of Suzan Obagi, MD’s line of skin care products throughout the United States. The launch is anticipated for mid-2017.
As quoted in the press release:

Established in 2013 with renowned cosmetic surgeon and dermatologist, Suzan Obagi, M.D., Nextcell Medical has been diligently working on new innovations that will change the industry’s approach to skin care. In their strategic relationship, Obagi and Nextcell have joined forces to introduce a next generation line of clinical skin care products. Obagi intends to continue to invest in Nextcell’s research and development efforts.
“I am so excited to finally unveil my line alongside the Obagi^® line of products,” said Suzan Obagi, M.D. “We have been working long and hard on designing a new concept of skin care for the modern patient. With our visions aligned, I can’t think of a better company than Obagi to introduce our products.”
“The relationship between Obagi and Nextcell is a forward move for this important brand,” said Joseph C. Papa, Chairman and CEO of Valeant. “Dr. Suzan Obagi brings extensive academic and clinical experience to the rich history of Obagi.”

Click here for the full press release.